The current state of peritoneal dialysis
R Mehrotra, O Devuyst, SJ Davies… - Journal of the American …, 2016 - journals.lww.com
Technical innovations in peritoneal dialysis (PD), now used widely for the long-term
treatment of ESRD, have significantly reduced therapy-related complications, allowing …
treatment of ESRD, have significantly reduced therapy-related complications, allowing …
Lipid management in patients with chronic kidney disease
An increased risk of cardiovascular disease, independent of conventional risk factors, is
present even at minor levels of renal impairment and is highest in patients with end-stage …
present even at minor levels of renal impairment and is highest in patients with end-stage …
Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017
AA Faludi, MCO Izar, JFK Saraiva… - Arquivos brasileiros de …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
V Diretriz brasileira de dislipidemias e prevenção da aterosclerose
HT Xavier, MC Izar, JR Faria Neto… - Arquivos brasileiros de …, 2013 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review
Objective Many published meta-analyses are underpowered. We explored the role of trial
sequential analysis (TSA) in assessing the reliability of conclusions in underpowered meta …
sequential analysis (TSA) in assessing the reliability of conclusions in underpowered meta …
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis
SC Palmer, JC Craig, SD Navaneethan… - Annals of internal …, 2012 - acpjournals.org
Background: Statins have uncertain benefits in persons with chronic kidney disease (CKD)
because individual trials may have insufficient power to determine whether treatment effects …
because individual trials may have insufficient power to determine whether treatment effects …
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
W Herrington, J Emberson, B Mihaylova… - Lancet Diabetes and …, 2016 - ora.ox.ac.uk
Background: Statin therapy is effective for the prevention of coronary heart disease and
stroke in patients with mild-to-moderate chronic kidney disease, but its effects in individuals …
stroke in patients with mild-to-moderate chronic kidney disease, but its effects in individuals …
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
Objective To analyse the benefits and harms of statins in patients with chronic kidney
disease (pre-dialysis, dialysis, and transplant populations). Design Meta-analysis. Data …
disease (pre-dialysis, dialysis, and transplant populations). Design Meta-analysis. Data …
Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis
A Upadhyay, A Earley, JL Lamont… - Annals of internal …, 2012 - acpjournals.org
Background: Lipid-lowering therapy is not widely used in persons with chronic kidney
disease (CKD) despite a high burden of dyslipidemia and cardiovascular disease in this …
disease (CKD) despite a high burden of dyslipidemia and cardiovascular disease in this …
Association of glucagon-like peptide-1 receptor agonist vs dipeptidyl peptidase-4 inhibitor use with mortality among patients with type 2 diabetes and advanced …
JJ Chen, CY Wu, CC Jenq, TH Lee, CY Tsai… - JAMA Network …, 2022 - jamanetwork.com
Importance Glucagon-like peptide-1 (GLP-1) receptor agonist use is associated with
reduced mortality and improved cardiovascular outcomes in the general population with …
reduced mortality and improved cardiovascular outcomes in the general population with …